## Opioid Pharmacokinetics in Acute Pain Management **Key Point:** Remifentanil is an ultra-short-acting synthetic opioid with a duration of action of 3–5 minutes, making it ideal for acute perioperative pain and procedural sedation. ### Mechanism of Rapid Offset Remifentanil is rapidly metabolized by non-specific plasma and tissue esterases, independent of hepatic or renal function. This ester metabolism allows for: - Rapid termination of effect even after prolonged infusion - Predictable recovery without accumulation - Minimal risk of prolonged respiratory depression ### Comparison with Other Opioids | Opioid | Duration | Metabolism | Clinical Use | |--------|----------|-----------|---------------| | Remifentanil | 3–5 min | Ester hydrolysis | Acute perioperative, procedural sedation | | Morphine | 3–4 hours | Hepatic glucuronidation | Acute and chronic pain | | Methadone | 24–36 hours | Hepatic N-demethylation | Chronic pain, opioid maintenance | | Buprenorphine | 6–8 hours (IV), 24–72 hours (transdermal) | Hepatic metabolism | Chronic pain, opioid dependence | **High-Yield:** Remifentanil is the gold standard for short procedures and acute pain requiring rapid titration and offset. Its context-sensitive half-time remains <10 minutes regardless of infusion duration, unlike other opioids that show prolonged half-times with extended use. **Clinical Pearl:** Remifentanil must be used with concurrent sedatives or hypnotics in conscious patients because it has no anxiolytic or amnestic properties—it is a pure analgesic. **Warning:** Remifentanil is expensive and requires careful infusion pump management; it cannot be given by bolus for acute pain outside the operating room setting. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.